Loading page
Tirzepatide
Tirzepatide
Dual GLP-1 and GIP receptor agonist
Dose
£149.99
1
Tirzepatide£149.99 · 40mg
- Check the batch. Match the batch on your product label to the available laboratory report.
- Read the original report. View test certificates and availability for your selected strength.
- Buyer guarantee. Arrives damaged or not matching its certificate? We’ll replace it or refund you.
Specification
- Form
- Prefilled research pen
- Storage
- Follow the storage conditions on the supplied product label.
- Purity
- Specification pending verification
For research and laboratory use only. Not for human consumption, diagnostic, or therapeutic use.
Test certificates
Tirzepatide · 40mg · Certificate available
Janoshik Analytical report for KLIKJARO 40MG. The original certificate is reproduced here and can be verified directly with the laboratory.
- Report
- #224432
- Batch
- 07/2026
- Analysed
This report applies to the named sample and batch. Check the batch on your product label against the report.
Read report results
- Tirzepatide
- 17.88 mg/ml
- Purity
- 99.304%
Purity assessment includes peptide peaks only.
Concentrations are reported in mg/ml, as stated by the laboratory.
View full-size certificate (opens in a new tab)The full picture
Tirzepatide is a dual agonist targeting the GLP-1 and GIP receptors, studied for its effects on appetite modulation, glucose regulation, and energy utilization. By activating these complementary metabolic pathways it is investigated in research settings as a tool for exploring balanced, sustained metabolic response.
Compound research references
These references describe the compounds. They do not certify the supplied product or batch.
What customers say
—0 reviews
No reviews yet — be the first to review Tirzepatide.
